Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial-Reference-Cited by-同舟云学术

Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial

Published:2014-11 Issue:12 Volume:15 Page:1369-1378
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Ramalingam Suresh S,Jänne Pasi A,Mok Tony,O'Byrne Kenneth,Boyer Michael J,Von Pawel Joachim,Pluzanski Adam,Shtivelband Mikhail,Docampo Lara Iglesias,Bennouna Jaafar,Zhang Hui,Liang Jane Q,Doherty Jim P,Taylor Ian,Mather Cecile B,Goldberg Zelanna,O'Connell Joseph,Paz-Ares Luis

Publisher

Elsevier BV

Subject

Oncology

Reference16 articles.

1. Recent clinical advances in lung cancer management;Johnson;J Clin Oncol,2014

2. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

3. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study;Cappuzzo;Lancet Oncol,2010

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

5. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Small-Molecule Dual Inhibitors Targeting EGFR and HER2 Receptors as Anti-Cancer Agents;Current Medicinal Chemistry;2024-06-10

2. Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach;Exploration of Targeted Anti-tumor Therapy;2024-05-17

3. Dacomitinib in EGFR-mutant non-small-cell lung cancer with brain metastasis: a single-arm, phase II study;ESMO Open;2023-12

4. Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer;Clinical and Translational Oncology;2023-08-11

5. Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors;Current Medicinal Chemistry;2023-06-26